Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-12

FDA Approved: ONTRALFY — Original Application (Rosemont Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved ONTRALFY (tizanidine hydrochloride) under an Original Application by Rosemont Pharmaceuticals, LLC for the management of muscle spasticity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONTRALFY (Tizanidine hydrochloride)

Snippet

ORIG AP for ONTRALFY (TIZANIDINE HYDROCHLORIDE)